Related Experiment Video
Updated: May 14, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current
Ravi Mangal Patel1, Patricia Wei Denning
1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive Northeast, 3rd Floor, Atlanta, GA 30322, USA.
Insights
Preventive therapies for necrotizing enterocolitis (NEC) are crucial for preterm infants. Probiotics show promise in reducing NEC, but safety and dosing require further investigation for routine clinical use.
Area of Science:
- Neonatal medicine
- Gastroenterology
- Microbiome research
Background:
- Necrotizing enterocolitis (NEC) is a significant cause of illness and death in newborns.
- Effective and safe preventive treatments for NEC are critically needed.
- Probiotics are currently the most promising therapeutic approach for NEC in preterm infants.
Purpose of the Study:
- To review current evidence on probiotics, prebiotics, and postbiotics for preterm infants.
- To evaluate the therapeutic role of these agents in preventing NEC.
- To address safety and dosing concerns regarding probiotic use.
Main Methods:
- Systematic review of existing therapeutic trials and scientific literature.
- Analysis of data on the efficacy and safety of probiotics, prebiotics, and postbiotics.
- Evaluation of current clinical practice guidelines and research gaps.
Main Results:
- Evidence suggests probiotics are effective in reducing NEC incidence in preterm infants.
- Safety and optimal dosing of probiotics remain areas of concern for widespread adoption.
- Prebiotics and postbiotics also present potential therapeutic benefits for NEC prevention.
Conclusions:
- Probiotics represent a promising strategy for NEC prevention in preterm neonates.
- Further research is needed to establish definitive safety protocols and optimal dosing regimens.
- A comprehensive approach involving probiotics, prebiotics, and postbiotics may offer future solutions for NEC management.
Abstract:
Necrotizing enterocolitis (NEC) is a leading cause of neonatal morbidity and mortality, and preventive therapies that are both effective and safe are urgently needed. Current evidence from therapeutic trials suggests that probiotics are effective in decreasing NEC in preterm infants, and probiotics are currently the most promising therapy for this devastating disease. However, concerns regarding safety and optimal dosing have limited the widespread adoption of routine clinical use of probiotics in preterm infants. This article summarizes the current evidence regarding the use of probiotics, prebiotics, and postbiotics in the preterm infant, including their therapeutic role in preventing NEC.
Related Concept Videos
Probiotics
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Intestinal Obstruction II: Pathophysiology

